Skip to main content
Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · IEX Real-Time Price · USD
1.225
-0.035 (-2.78%)
At close: Jul 19, 2024, 4:00 PM
1.260
+0.035 (2.86%)
Pre-market: Jul 22, 2024, 7:32 AM EDT

Seres Therapeutics Revenue

Seres Therapeutics had revenue of $126.85M in the twelve months ending March 31, 2024, with 2,380.87% growth year-over-year. In the year 2023, Seres Therapeutics had annual revenue of $126.33M with 1,672.24% growth.

Revenue (ttm)
$126.85M
Revenue Growth
+2,380.87%
P/S Ratio
1.46
Revenue / Employee
$544,408
Employees
233
Market Cap
185.52M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023126.33M119.20M1,672.24%
Dec 31, 20227.13M-137.80M-95.08%
Dec 31, 2021144.93M111.71M336.33%
Dec 31, 202033.22M-1.29M-3.74%
Dec 31, 201934.51M6.24M22.07%
Dec 31, 201828.27M-3.83M-11.94%
Dec 31, 201732.10M10.33M47.48%
Dec 31, 201621.77M--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

MCRB News

More News